Skip to main content
. 2021 Aug 3;11(8):1035. doi: 10.3390/brainsci11081035

Figure 2.

Figure 2

Effect of 3,4-diamniopyride treatment in LEMS. 3,4-diaminopyridine (3,4-DAP) blocks the efflux of potassium (K+) prolonging the presynaptic depolarization, which in turn prolongs the VGCCs opening time, allowing the influx of an increased amount of calcium ions with consequently increased ACh release.